Login Register
English
0

Cart

$ 0
OR
Catalog no Product name Protocol name IF Magazine title
BMS0050 Normal Goat Serum S100A16 suppresses the proliferation, migration and invasion of colorectal cancer cells in part via the JNK/p38 MAPK pathway(BMS0050-3.6) 3.6 Molecular Medicine Reports
A21020 HRP, Goat Anti-Rabbit IgG Expression of nuclear factor erythroid‑2‑related factor 2, broad complex‑tramtrack‑bric a brac and Cap‘n’collar homology 1 and γ‑glutamic acid cysteine synthase in peripheral blood of patients with chronic obstructive pulmonary disease and its clinical significance(A21020-1.73) 1.73 Experimental and Therapeutic Medicine
K22020 Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway(K22020-4.696) 4.696 Biomedicine & Pharmacotherapy
A21020 HRP, Goat Anti-Rabbit IgG microRNA-1388-5p inhibits NF-κB signaling pathway in miiuy croaker through targeting IRAK1(A21020-6) 6 Developmental & Comparative Immunology
A21010 HRP, Goat Anti-Mouse IgG microRNA-1388-5p inhibits NF-κB signaling pathway in miiuy croaker through targeting IRAK1(A21010-6) 6 Developmental & Comparative Immunology
A23620 Dylight 649, Goat Anti-Rabbit IgG Hepatitis B Surface Antigen Suppresses the Activation of Nuclear Factor Kappa B Pathway via Interaction With the TAK1-TAB2 Complex(A23620-5.4) 5.4 Frontiers in Immunology
A25112 IPKine™ HRP, Goat Anti-Mouse IgG HCS Nedd4-2 haploinsufficiency in mice causes increased seizure susceptibility and impaired Kir4.1 ubiquitination(A25112-7.7) 7.7 Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
KTA4001 Mitochondrial Membrane Potential Assay Kit (JC-1) Comparison of IVF and IVM outcomes in the same patient treated with a modified IVM protocol along with an oocytes-maturing system containing melatonin: A pilot study(KTA4001-3.647) 3.647 Life Sciences
A25012 IPKine™ HRP, Goat Anti-Mouse IgG LCS MiR-21-3p Promotes Hepatocellular Carcinoma Progression via SMAD7/YAP1 Regulation(A25012-3.5) 3.5 Frontiers in Oncology
K22020 miRNA‐194 predicts favorable prognosis in gastric cancer and inhibits gastric cancer cell growth by targeting CCND1(K22020-3) 3 FEBS Open Bio